SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-087899
Filing Date
2024-07-30
Accepted
2024-07-30 16:30:09
Documents
12
Period of Report
2024-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20240726.htm   iXBRL 8-K 47668
2 EX-10.1 drrx-ex10_1.htm EX-10.1 81269
  Complete submission text file 0000950170-24-087899.txt   298535

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20240726.xsd EX-101.SCH 52690
14 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20240726_htm.xml XML 6106
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 241157916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)